Andreas Perniok

618 total citations
15 papers, 478 citations indexed

About

Andreas Perniok is a scholar working on Rheumatology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andreas Perniok has authored 15 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 3 papers in Nephrology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andreas Perniok's work include Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Andreas Perniok is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Andreas Perniok collaborates with scholars based in Germany, United States and France. Andreas Perniok's co-authors include Christof Specker, Martin Herrmann, M. Schneider, M. Gaubitz, Norma Jung, A. Rubbert, Matthias Schneider, Joachim Feldkamp, Matthias Schneider and Wolfram Domschke and has published in prestigious journals such as American Journal Of Pathology, Annals of the Rheumatic Diseases and European Journal of Immunology.

In The Last Decade

Andreas Perniok

15 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Perniok Germany 11 260 233 105 61 59 15 478
Jean‐Frédéric Boyer France 10 181 0.7× 323 1.4× 109 1.0× 40 0.7× 22 0.4× 15 553
Gengru Jiang China 14 182 0.7× 130 0.6× 168 1.6× 65 1.1× 180 3.1× 34 530
G Pannarale Italy 10 104 0.4× 117 0.5× 179 1.7× 117 1.9× 156 2.6× 15 504
Zsuzsa Sándor Hungary 10 105 0.4× 194 0.8× 120 1.1× 53 0.9× 10 0.2× 15 456
Punchong Hanvivadhanakul Thailand 7 305 1.2× 359 1.5× 58 0.6× 10 0.2× 46 0.8× 11 481
Haitao Yu China 8 200 0.8× 232 1.0× 66 0.6× 17 0.3× 18 0.3× 13 378
Melissa Northcott Australia 9 272 1.0× 253 1.1× 51 0.5× 18 0.3× 26 0.4× 13 457
Magdalena Dryglewska Poland 12 68 0.3× 144 0.6× 63 0.6× 36 0.6× 20 0.3× 36 359
Ana Molina Spain 8 157 0.6× 63 0.3× 90 0.9× 19 0.3× 49 0.8× 9 326
Gunnbjørg Hjeltnes Norway 9 100 0.4× 212 0.9× 55 0.5× 21 0.3× 20 0.3× 13 320

Countries citing papers authored by Andreas Perniok

Since Specialization
Citations

This map shows the geographic impact of Andreas Perniok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Perniok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Perniok more than expected).

Fields of papers citing papers by Andreas Perniok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Perniok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Perniok. The network helps show where Andreas Perniok may publish in the future.

Co-authorship network of co-authors of Andreas Perniok

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Perniok. A scholar is included among the top collaborators of Andreas Perniok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Perniok. Andreas Perniok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Jung, Norma, Clara Lehmann, Ingo Haase, et al.. (2010). An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). Clinical Rheumatology. 29(10). 1169–1173. 47 indexed citations
2.
Taubert, Dirk, Andreas Lazar, Gundula Grimberg, et al.. (2006). Association of rheumatoid arthritis with ergothioneine levels in red blood cells: a case control study.. PubMed. 33(11). 2139–45. 37 indexed citations
3.
Iking‐Konert, Christof, Susan Jill Stocks, Frank Weinsberg, et al.. (2004). First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104. Annals of the Rheumatic Diseases. 63(9). 1104–1112. 15 indexed citations
4.
Hammer, Mark M., H. Kellner, R. Miehlke, et al.. (2003). Rheumatologie. 1 indexed citations
5.
Aisenbrey, Sabine, et al.. (2003). Vogt–Koyanagi–Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up. Graefe s Archive for Clinical and Experimental Ophthalmology. 241(12). 996–999. 16 indexed citations
6.
Perniok, Andreas & Andrea Rubbert‐Roth. (2003). Neue Therapieans�tze bei rheumatoider Arthritis durch Inhibition von kostimulatorischen Molek�len (CTLA4Ig) und Blockade der Interleukin-6-Rezeptorinteraktion (MRA). Zeitschrift für Rheumatologie. 62(5). 433–438. 1 indexed citations
7.
Kurth, Julia, Andreas Perniok, Roland Schmitz, et al.. (2002). Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody-producing cell lines. European Journal of Immunology. 32(12). 3785–3792. 7 indexed citations
8.
Plüm, J., Peter Razeghi, Andreas Perniok, et al.. (2001). Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells. American Journal of Kidney Diseases. 38(4). 867–875. 29 indexed citations
9.
Perniok, Andreas, et al.. (1999). Effect of 1α,25(OH)2-Vitamin D3on TNFα-Mediated Apoptosis of Human Primary Osteoblast-Like Cellsin Vitro. Hormone and Metabolic Research. 31(12). 653–656. 17 indexed citations
10.
Feldkamp, Joachim, et al.. (1999). Fas-Mediated Apoptosis is Inhibited by TSH and Iodine in Moderate Concentrations in Primary Human Thyrocytesin Vitro. Hormone and Metabolic Research. 31(6). 355–358. 15 indexed citations
11.
Müschen, Markus, Ulrich Warskulat, Andreas Perniok, et al.. (1999). Involvement of Soluble CD95 in Churg-Strauss Syndrome. American Journal Of Pathology. 155(3). 915–925. 48 indexed citations
12.
Perniok, Andreas, et al.. (1998). High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus. 7(2). 113–118. 172 indexed citations
14.
Gaubitz, M., Matthias F. Seidel, Heiko Schotte, et al.. (1998). Prospective Randomized Trial of Two Different Immunoadsorbers in Severe Systemic Lupus Erythematosus. Journal of Autoimmunity. 11(5). 495–501. 52 indexed citations
15.
Schneider, Marie Paule, M. Gaubitz, & Andreas Perniok. (1997). Immunoadsorption in Systemic Connective Tissue Diseases and Primary Vasculitis. Therapeutic Apheresis. 1(2). 117–120. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026